Products

API CAS 71125-38-7 Meloxicam Purity Meloxicam Powder Material Meloxicam

China API CAS 71125-38-7 Meloxicam Purity Meloxicam Powder Material Meloxicam, Find details about China Meloxicam, Powder Meloxicam from API CAS 71125-38-7 Meloxicam Purity Meloxicam Powder Material Meloxicam

Model NO.
D-sung Meloxicam
Product Name
Meloxicam
Name
Meloxicam Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Treatment Rheumatoid Arthritis
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
71125-38-7
Mf
C14h13n3o4s2
MW
351.40072
Density
1.613
Melting Point
255°c
Trademark
D-sung
Transport Package
Negotiable
Specification
99%
Origin
Shaanxi Xi′an
Model NO.
D-sung Meloxicam
Product Name
Meloxicam
Name
Meloxicam Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Treatment Rheumatoid Arthritis
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
71125-38-7
Mf
C14h13n3o4s2
MW
351.40072
Density
1.613
Melting Point
255°c
Trademark
D-sung
Transport Package
Negotiable
Specification
99%
Origin
Shaanxi Xi′an
API CAS 71125-38-7 Meloxicam Purity Meloxicam Powder Material Meloxicam
API CAS 71125-38-7 Meloxicam Purity Meloxicam Powder Material Meloxicam
Product Description
API CAS 71125-38-7 Meloxicam Purity Meloxicam Powder Material MeloxicamAPI CAS 71125-38-7 Meloxicam Purity Meloxicam Powder Material Meloxicam
Product Details
API CAS 71125-38-7 Meloxicam Purity Meloxicam Powder Material Meloxicam
Product nameMeloxicam
Cas number71125-38-7
ApperanceLight Yellow to Yellow Powder
Density1.613
MFC14H13N3O4S2
Melting point255°C
MW351.40072
Meloxicam is a non-steroid antipyretic, analgesic and anti-inflammatory drug. It is not a hormone drug and has strong anti-inflammatory, analgesic and antipyretic effects. It can selectively inhibit the activity of cyclocxygenase-2 (COX-2), thereby blocking the synthesis of prostaglandins. The inhibition of prochemicalbook adenosin biosynthesis in inflammatory sites was stronger than that of prostaglandin biosynthesis in gastric mucosa or kidney, and was safer than other NSAIDs. It is mainly used to relieve the symptoms of osteoarthritis, painful osteoarthritis, rheumatoid arthritis and severe spondylitis of the joints.
Application&Function
API CAS 71125-38-7 Meloxicam Purity Meloxicam Powder Material MeloxicamOlder patients and patients with an increased risk of adverse reactions;
In elderly patients, patients with rheumatoid arthritis and ankylosing spondylitis treatment recommended dose for 7.5mg/days. Starting dose in patients with increased risk of adverse reactions to 7.5mg/days.
Patients with renal insufficiency:
Patients with severe renal failure and need dialysis, the dose should not exceed 7.5mg/days.
Patients with mild to moderate renal insufficiency do not need to adjust the dosage (such as patients with creatinine clearance greater than 25ml/minutes).
Patients with severe renal failure without dialysis.
Patients with hepatic insufficiency: In patients with mild and moderate hepatic insufficiency no need to adjust the dose.
In patients with severe hepatic insufficiency.
Children: This product is not for use in children under 15 years of age. Meloxicam has other forms, may apply.
Specification
API CAS 71125-38-7 Meloxicam Purity Meloxicam Powder Material MeloxicamAPI CAS 71125-38-7 Meloxicam Purity Meloxicam Powder Material MeloxicamAPI CAS 71125-38-7 Meloxicam Purity Meloxicam Powder Material MeloxicamAPI CAS 71125-38-7 Meloxicam Purity Meloxicam Powder Material MeloxicamAPI CAS 71125-38-7 Meloxicam Purity Meloxicam Powder Material MeloxicamAPI CAS 71125-38-7 Meloxicam Purity Meloxicam Powder Material MeloxicamAPI CAS 71125-38-7 Meloxicam Purity Meloxicam Powder Material Meloxicam
 

 

You Might Also Like